AA
RDHL

Ancora Advisors’s Redhill Biopharma RDHL Stock Holding History

Ancora Advisors’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-164
Closed -$82K – 1921
2022
Q3 		$82K Buy
164
+82
+100% +$71.4K ﹤0.01% 959
2022
Q2 		$71K Hold
82
– – ﹤0.01% 1066
2022
Q1 		$207K Sell
82
-2
-2% -$4.74K 0.01% 784
2021
Q4 		$218K Buy
84
+46
+121% +$184K 0.01% 775
2021
Q3 		$172K Buy
+38
New +$258K ﹤0.01% 824

Other funds holding RDHL

SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
CAM
Claret Asset Management Montreal, Quebec, Canada $928M AUM 25.4% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $171B AUM 24.68% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Ancora Advisors's RDHL Position: Q4 2022 in Review

Ancora Advisors sold out of Redhill Biopharma (RDHL) in Q4 2022, closing a stake of 164 shares — an estimated $82K sold.

Ancora Advisors first reported a position in RDHL in Q3 2021 and held it in 5 quarters. The position peaked at $218K in Q4 2021. 37 funds tracked by Wall St. Rank hold RDHL as of Q4 2022.

  • Ancora Advisors reported no remaining Redhill Biopharma position as of Q4 2022 after selling out during the quarter.
  • Ancora Advisors sold 164 Redhill Biopharma shares in Q4 2022, an estimated $82K.
  • Ancora Advisors first reported a position in Redhill Biopharma in Q3 2021 and held it in 5 quarters.
  • Ancora Advisors's Redhill Biopharma position peaked at $218K in Q4 2021.
  • 37 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2022.

Based on Ancora Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.